Scilex Holding Company (SCLX)

NASDAQ: SCLX · USD

$2.05

+0.00 (0.0%)· Recorded snapshot

Market cap	14.4M
Revenue (ttm)	31.6M
Net income (ttm)	-448.3M
EPS (ttm)	-$51.6
Shares out	7M
Volume	15,216
Beta	1.79

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 31.6M
Net income (ttm): -448.3M
EPS (ttm): -$51.6
Market cap: 14.4M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Mantenere

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 13.4P50 20.2P75 35.7

Trailing P/En/a

P25 15.4P50 25.8P75 43.5

ROEn/a

P25 -113.8P50 -46.5P75 -0.9

ROICn/a

P25 -68.5P50 -27.1P75 1.8

Benchmarks · 1M

All SCLX indicators

Market & fundamental data

Available fields

197

Groups with data

Currency

USD

Showing 197 of 197 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001820190
Company name	Scilex Holding Company
Country	United States
Country code	US
CUSIP number	80880W205
Earnings date	2026-11-13
Earnings time	amc
Employees	34
Employees change	-81
Employees growth	-70.43%
Enterprise value	$119.8M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2011
Industry	Drug Manufacturers - General
Is primary listing	Yes
Is SPAC	No
ISIN number	US80880W2052
Last 10-K release date	2026-04-10
Last earnings date	2026-08-14
Last refreshed	2026-10-28
Last stock split date	2025-04-15
Last stock split type	Reverse
Market cap	$14.4M
Market cap category	Nano-Cap
Next earnings date	2026-11-13
Options	No
Price	$2.05
Price currency	USD
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-28
Symbol	SCLX
U.S. state	California
Website	https://www.scilexholding.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-2,517.07%
EV/Sales	3.79x
FCF / EV yield	-14.86%
FCF yield	-122.91%
Industry forward P/E	18.51x
Industry P/E	35.9x
P/S ratio	0.46x
Sector forward P/E	23.56x
Sector P/E	50.13x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	55.5%
Operating margin	-903.52%
Pretax margin	-1,469.71%
Profit per employee	$-13.2M
Revenue per employee	$929,647
ROA	-105.83%
ROA (5Y)	-54.16%
ROCE	110.4%
SBC / revenue	54.69%
Tax / revenue	0.04%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	0
Gross profit growth	-43.64%
Gross profit growth (Q)	-40.14%
Gross profit growth 3Y	-16.9%
Gross profit growth 5Y	2.86%
Net income growth years	0
Revenue growth	-28.55%
Revenue growth (Q)	-22.78%
Revenue growth (QoQ)	-11.27%
Revenue growth 3Y	-12.05%
Revenue growth 5Y	8.49%
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-726,000
Depreciation and amortization	$8.3M
EBIT	$-285.6M
EBITDA	$-277.3M
EPS	$-51.60
FCF per share	$-2.53
Financing cash flow	$10.9M
Free cash flow	$-17.8M
Free cash flow minus SBC	$-35.1M
Gross profit	$17.5M
Income taxes	$14,000
Investing cash flow	$3.9M
Net borrowing	$-2.1M
Net cash flow	$-3.5M
Net income	$-448.3M
Operating cash flow minus SBC	$-34.4M
Operating income	$-285.6M
Revenue	$31.6M
Stock-based compensation	$17.3M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-11.72
Book value per share	$-43.83
Goodwill	$13.5M
Interest coverage	-15.99
Long-term assets	$217.3M
Long-term liabilities	$51.8M
Net cash (debt)	$-105.4M
Net cash / market cap	-727.35%
Piotroski F-Score	1
Property, plant and equipment	$26.8M
Shareholders' equity	$-310.5M
Tangible book value	$-379.4M
Tangible book value per share	$-53.93
Total assets	$253.6M
Total cash	$581,000
Total debt	$106M
Total liabilities	$564.1M
WACC	13.41%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.19
Current assets	$36.2M
Current liabilities	$512.2M
Current ratio	0.07
Inventory turnover	4.21
Net working capital	$-388.2M
Quick ratio	0.05
Working capital	$-476M
Working capital turnover	-0.08

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	37.27%
Dividend yield	0%
Shareholder yield	37.27%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$6.35
1D price change	0%
1M price change	-58.08%
1M total return	-58.08%
1W price change	-18.97%
1W total return	-18.97%
1Y price change	-89.2%
1Y return CAGR	-82.68%
1Y total return	-82.66%
20-day SMA	$2.94
200-day SMA	$6.97
3M price change	-70.84%
3M total return	-70.84%
3Y price change	-96.82%
3Y return CAGR	-62.88%
3Y total return	-94.89%
50-day SMA	$4.32
50-day SMA vs 200-day SMA	50under200
52-week high	$27.00
52-week high date	2025-11-21
52-week low	$2.01
52-week low date	2026-10-28
5Y price change	-99.42%
5Y return CAGR	-60.73%
5Y total return	-99.06%
6M price change	-70.2%
6M total return	-52.15%
All-time high	$591.50
All-time high date	2023-04-05
All-time low	$2.01
All-time low date	2026-10-27
Average true range (ATR)	$0.27
Average volume	49.8K
Beta (1Y)	1.5
Beta (2Y)	0.58
Beta (5Y)	1.79
Change from 52-week high	-92.41%
Change from 52-week low	1.99%
Change from all-time high	-99.65%
Change from all-time low	1.99%
Change from open	0.99%
Day's gap	-0.98%
Dollar volume	$31,193
High price	$2.05
Low price	$2.03
Monthly RSI	31.92
Open price	$2.03
Position in 52-week range	100%
Premarket change	-0.49%
Premarket close	$2.05
Premarket price	$2.04
Previous close	$2.05
Price vs 150-day SMA	-67.74%
Price vs 20-day SMA	-30.18%
Price vs 200-day SMA	-70.61%
Price vs 50-day SMA	-52.5%
Relative volume	0.31
RSI	14.27
Sharpe ratio	-1.32
Sharpe ratio (3Y)	-0.28
Sharpe ratio (5Y)	-0.28
Sortino ratio	-1.95
Sortino ratio (3Y)	-0.37
Sortino ratio (5Y)	-0.37
Volume	15.2K
Weekly RSI	30.51
YTD price change	-83.2%
YTD total return	-73.01%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	5.7M
Float percentage	80.89%
Shares change (QoQ)	0.01%
Shares change (YoY)	-37.27%
Shares held by insiders	4.69%
Shares held by institutions	10.22%
Shares outstanding	7M
Short % of float	3.01%
Short % of shares	2.43%
Short ratio	5.7 days

Deeper analysis on SCLX

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this SCLX report

Is a complete SCLX research report available?

No complete published report is available for Scilex Holding Company (SCLX) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Scilex Holding Company (SCLX)

Price

Financial snapshot

Fair-value bridge

Latest news · SCLX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All SCLX indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on SCLX

Frequently asked questions